Abstract
In previously apparently healthy women, glucose intolerance and high blood pressure during pregnancy are common and frequently occur together. This article reviews the role of these gestational disorders as markers of vascular dysfunction and its pathophysiology. Mechanisms include alterations to function of large arteries and resistance vessels and to capillary blood flow. Much of the vessel pathology is seen in both gestational diabetes and hypertension. In women who have had transient diabetes during pregnancy and later redeveloped overt diabetes, cardiovascular risk is already elevated nearly fourfold before diagnosis, which is almost as high as the average risk after a clinical diagnosis of diabetes is made. This key finding suggests that vascular risk in such women is at least partly independent of overt hyperglycemia.
Key Points
-
Gestational diabetes and gestational hypertensive disorders might have common underlying pathophysiological mechanisms
-
Gestational diabetes and gestational hypertensive disorders are associated with vascular dysfunction demonstrable in small and large vessels
-
Long-term follow-up studies seem not to have been done in women with gestational diabetes, although studies in women with gestational hypertensive disorders have demonstrated raised cardiovascular risk
-
Early intervention in women with gestational diabetes or hypertension, as well as better definition of their risk, could help to prevent future cardiovascular disease
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McKay J and Mensah GA (Eds; 2004) The Atlas of Heart Disease and Stroke. Geneva: WHO
Cruickshank JK et al. (2005) Origins of the “black/white” difference in blood pressure: roles of birth weight, postnatal growth, early blood pressure, and adolescent body size: the Bogalusa Heart Study. Circulation 111: 1932–1937
Smith GC et al. (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357: 2002–2006
Adams EM and Macgillivray I (1961) Long-term effect of preeclampsia on blood-pressure. Lancet 2: 1373–1375
Seely EW (1999) Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab 84: 1858–1861
Kaaja RJ and Greer IA (2005) Manifestations of chronic disease during pregnancy. JAMA 294: 2751–2757
Wilson BJ et al. (2003) Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 326: 845
Lesauskaite V et al. (1999) World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. Nutr Metab Cardiovasc Dis 9: 266–276
Stokes J III et al. (1987) The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 75: V65–V73
Mosca L et al. (1997) Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 96: 2468–2482
Williams MR et al. (2001) Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 86: 5389–5395
Grady D (2003) Myocardial infarction during menses: lessons from trials and errors. Am J Med 114: 611–612
Hu FB et al. (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25: 1129–1134
Hu G et al. (2005) Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48: 856–861
Hu G et al. (2005) The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 45: 1413–1418
Natarajan S et al. (2003) Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163: 1735–1740
Hadden DR (2002) Pregnancy and Diabetes. In Oxford textbook of endocrinology and diabetes, 1799–1807 (Eds Wass JAH and Shalet SM) Oxford: Oxford University Press
Crowther CA et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477–2486
The HAPO Study Cooperative Research Group (2002) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet 78: 69–77
Omar HA et al. (1998) Reduction of the human placental vascular relaxation to progesterone by gestational diabetes. J Matern Fetal Investig 8: 27–30
Dollberg S et al. (1997) Nitric oxide synthase activity in umbilical and placental vascular tissue of gestational diabetic pregnancies. Gynecol Obstet Invest 44: 177–181
Pustovrh C et al. (2000) Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev 12: 269–275
Coughlan MT et al. (2004) Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25: 78–84
Babawale MO et al. (2000) Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia 43: 1185–1196
Saldeen P et al. (2002) Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 105: 136–142
Knock GA et al. (1997) Association of gestational diabetes with abnormal maternal vascular endothelial function. Br J Obstet Gynaecol 104: 229–234
Paradisi G et al. (2002) Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 25: 560–564
Hu J et al. (1998) Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 105: 1279–1287
Hannemann MM et al. (2002) Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 39: 311–319
Anastasiou E et al. (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21: 2111–2115
Heitritter SM et al. (2005) Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90: 3983–3988
National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183: S1–S22
Naicker T et al. (2003) Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 82: 722–729
Vainio M et al. (2004) Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta Obstet Gynecol Scand 83: 1119–1123
Vanderlelie J et al. (2005) Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 26: 53–58
Merchant SJ et al. (2004) The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 23: 47–60
Sgambati E et al. (2004) VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 111: 564–570
Levine RJ et al. (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293: 77–85
Myers J et al. (2005) In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 45: 258–263
Sibai BM et al. (1992) Eclampsia. VII: pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 166: 1757–1761
Marin R et al. (2000) Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy 19: 199–209
Norden Lindeberg S and Hanson U (2000) Hypertension and factors associated with metabolic syndrome at follow-up at 15 years in women with hypertensive disease during first pregnancy. Hypertens Pregnancy 19: 191–198
Pouta A et al. (2004) Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 43: 825–831
Wolf M et al. (2004) Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89: 6239–6243
Ong SS et al. (2002) Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with pre-eclampsia. Hypertens Pregnancy 21: 175–183
Agatisa PK et al. (2004) Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 286: H1389–H1393
Chambers JC et al. (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285: 1607–1612
McCarthy AL et al. (1993) Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 168: 1323–1330
Wimalasundera RC et al. (2005) Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman. Am J Obstet Gynecol 192: 625–632
Knock GA and Poston L (1996) Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175: 1668–1674
Suzuki Y et al. (2000) Mechanisms underlying the reduced endothelium-dependent relaxation in human omental resistance artery in pre-eclampsia. J Physiol 527: 163–174
Savvidou MD et al. (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361: 1511–1517
Elvan-Taspinar A et al. (2005) Stiffness of the arterial wall, joints and skin in women with a history of pre-eclampsia. J Hypertens 23: 147–151
Novelli GP et al. (2003) Are gestational and essential hypertension similar? Left ventricular geometry and diastolic function. Hypertens Pregnancy 22: 225–237
Blaauw J et al. (2005) Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstet Gynecol 105: 626–632
Eneroth-Grimfors E et al. (1993) Noninvasive test of microvascular endothelial function in normal and hypertensive pregnancies. Br J Obstet Gynaecol 100: 469–471
Davis KR et al. (2001) Microvascular vasodilator response to acetylcholine is increased in women with pre-eclampsia. BJOG 108: 610–614
Beinder E and Schlembach D (2001) Skin flux during reactive hyperemia and local hyperthermia in patients with preeclampsia. Obstet Gynecol 98: 313–318
Charkoudian N (2003) Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc 78: 603–612
Bryson CL et al. (2003) Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol 158: 1148–1153
Kvetny J and Poulsen HF (2003) Incidence of gestational hypertension in gestational diabetes mellitus. Arch Gynecol Obstet 267: 153–157
Yamamoto T et al. (2005) Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia. Am J Obstet Gynecol 192: 558–563
Loukovaara M et al. (2005) Concentration of cord serum placenta growth factor in normal and diabetic pregnancies. BJOG 112: 75–79
Ostlund I et al. (2004) Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol 113: 12–16
Barden A et al. (2004) Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 22: 2371–2378
Yogev Y et al. (2004) Pre-eclampsia and gestational diabetes mellitus: does a correlation exist early in pregnancy? J Matern Fetal Neonatal Med 15: 39–43
Vambergue A et al. (2002) Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the Diagest study. Eur J Obstet Gynecol Reprod Biol 102: 31–35
Joffe GM et al. (1998) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 179: 1032–1037
Kougias P et al. (2005) Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126: 121–129
Ramsay JE et al. (2003) Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 42: 891–894
Hendler I et al. (2005) The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 193: 979–983
Naruse K et al. (2005) Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 65: 65–75
Kinalski M et al. (2005) Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 37: 450–454
Retnakaran R et al. (2005) Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48: 993–1001
Worda C et al. (2004) Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 191: 2120–2124
Laurent S et al. (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236–1241
Cruickshank JK et al. (2002) Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106: 2085–2090
Williams B et als. (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113: 1213–1225
Acknowledgements
We thank Ms J Stewart and Miss K Molloy for help in preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Banerjee, M., Cruickshank, J. Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk. Nat Rev Cardiol 3, 596–603 (2006). https://doi.org/10.1038/ncpcardio0683
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0683
This article is cited by
-
Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?
Current Atherosclerosis Reports (2020)
-
Addressing the Gap in Physician Preparedness To Assess Cardiovascular Risk in Women: a Comprehensive Approach to Cardiovascular Risk Assessment in Women
Current Treatment Options in Cardiovascular Medicine (2019)
-
Early cardiovascular events in women with a history of gestational diabetes mellitus
Cardiovascular Diabetology (2016)
-
Preeclampsia and health risks later in life: an immunological link
Seminars in Immunopathology (2016)
-
Need for insulin to control gestational diabetes is reflected in the ambulatory arterial stiffness index
BMC Pregnancy and Childbirth (2013)